During the past decade, LTD L. Managadze National Center of Urology, Department of Urology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "LTD L. Managadze National Center of Urology, Department of Urology" are "Bladder Cancer" (3 trials), "Urothelial Carcinoma" (3 trials), "Urothelial Carcinoma Bladder" (2 trials), "Chemotherapy-induced Neutropenia" (1 trials) and "Chronic Kidney Diseases" (1 trials). Many other conditions were trialed in "LTD L. Managadze National Center of Urology, Department of Urology" in a lesser frequency.

Most popular intervention types in "LTD L. Managadze National Center of Urology, Department of Urology" are "Drug" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "UGN-102" (2 trials), "Avelumab" (1 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "LTD L. Managadze National Center of Urology, Department of Urology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "LTD L. Managadze National Center of Urology, Department of Urology". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in LTD L. Managadze National Center of Urology, Department of Urology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in LTD L. Managadze National Center of Urology, Department of Urology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".